Evidence map›Paper›PMID 38556602›Full record

ReviewCellular and molecular life sciences : CMLS2024

Regulation and function of transposable elements in cancer genomes.

Michael Lee, Syed Farhan Ahmad, Jian Xu

Open access · goldAbstract readReview
In one paragraph

Review in Cellular and molecular life sciences : CMLS, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
17.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Technologies for engineering repetitive DNA.Quantitative biology (Beijing, China) · 2026
    Review
  3. Review
  4. Chromosome-Level Genome Assembly ofJournal of fungi (Basel, Switzerland) · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Revisiting Clonal Evolution Through the Light of Retrotransposons.BioEssays : news and reviews in molecular, cellular and developmental biology · 2025
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Transposons disrupt genomic stability and trigger cancers.Frontiers in cellular and infection microbiology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Michael LeeDepartment of Pediatrics, Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, 6000 Harry Hines Blvd., Dallas, TX, 75390, USA. MichaelJr.Lee@UTSouthwestern.edu.
Syed Farhan AhmadDepartment of Pathology, Center of Excellence for Leukemia Studies, St. Jude Children's Research Hospital, 262 Danny Thomas Place - MS 345, Memphis, TN, 38105, USA.
Jian XuDepartment of Pathology, Center of Excellence for Leukemia Studies, St. Jude Children's Research Hospital, 262 Danny Thomas Place - MS 345, Memphis, TN, 38105, USA. jian.xu@stjude.org.ORCID http://orcid.org/0000-0003-1988-7337
St. Jude Children's Research Hospital · USChildren's Medical Center · US

Funding

Molecular Analysis of Transcriptional Enhancers in HematopoiesisR01DK111430 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI Jian Xu · 2016 to 2026
$4.8M
Elucidating the Functional and Mechanistic Roles of LINE-1 Retrotransposons in Myeloid LeukemiaR01CA259581 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI Jian Xu · 2022 to 2026
$2.3M
Targeting Metabolic Liabilities of Leukemia-Initiating Cells (R01CA230631)R01CA230631 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI XU, JIAN · 2019 to 2023
$1.8M
Dissecting the functional role of LINE1 retrotransposon-mediated interferon signaling in myeloid leukemiaF30CA275292 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI LEE, MICHAEL · 2022 to 2025
$179k
NCI NIH HHS F30 CA275292NCI NIH HHS R01 CA230631NCI NIH HHS R01 CA259581NIDDK NIH HHS R01 DK111430NIH HHS F30CA275292NIH HHS R01CA230631NIH HHS R01CA259581NIH HHS R01DK111430
6 · The paper itself

Abstract

Over half of human genomic DNA is composed of repetitive sequences generated throughout evolution by prolific mobile genetic parasites called transposable elements (TEs). Long disregarded as "junk" or "selfish" DNA, TEs are increasingly recognized as formative elements in genome evolution, wired intimately into the structure and function of the human genome. Advances in sequencing technologies and computational methods have ushered in an era of unprecedented insight into how TE activity impacts human biology in health and disease. Here we discuss the current views on how TEs have shaped the regulatory landscape of the human genome, how TE activity is implicated in human cancers, and how recent findings motivate novel strategies to leverage TE activity for improved cancer therapy. Given the crucial role of methodological advances in TE biology, we pair our conceptual discussions with an in-depth review of the inherent technical challenges in studying repeats, specifically related to structural variation, expression analyses, and chromatin regulation. Lastly, we provide a catalog of existing and emerging assays and bioinformatic software that altogether are enabling the most sophisticated and comprehensive investigations yet into the regulation and function of interspersed repeats in cancer genomes.

Indexed as

DNA Transposable ElementsNeoplasmsComputational BiologyEvolution, MolecularGenome, HumanHumansDNA Transposable ElementsERVsLINE-1Long-read sequencingNon-coding genomeRetrotransposonsSINEViral mimicry

Identifiers

PMID38556602
PMCPMC10982106
OpenAlexW4393357390

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.